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ABSTRACT 
Erica Johanna Roelofs: Effects of pomegranate extract on anaerobic exercise performance & 
cardiovascular responses 
 (Under the direction of Dr. Abbie E. Smith-Ryan) 
 
The purpose of this study was to evaluate the effects of pomegranate extract (PE) on 
anaerobic exercise and flow mediated dilation (FMD). In a randomized, crossover design, 
nineteen participants completed repeated sprint ability (RSA) tests and repetitions to fatigue 
(RTF) on bench press and leg press with consumption of PE or placebo. Brachial artery FMD was 
assessed by ultrasound to determine blood flow and vessel diameter. FMD was assessed at 
baseline, 30min post ingestion, immediately post exercise (IPost), and 30min post exercise 
(30minPostEx). With PE, blood flow significantly increased IPost RSA (mean difference 
[MD]=18.49 mL·min-1; p=0.05), and IPost and 30minPostEx RTF (p<0.05). Vessel diameter 
increased significantly 30minPostEx of RSA, and IPost and 30minPostEx RTF (p<0.05). With PE, 
power output increased significantly halfway (sprint 5 of 10) through the RSA (MD=31.81 Watts; 
p=0.046). Supplementation of PE augmented vessel diameter, blood flow and power, supporting 
ergogenic effects and enhanced vasodilation. 
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CHAPTER I 
INTRODUCTION 
  
Nutritional supplements taken before exercise that increase nitrate concentration, such as 
pomegranate and beetroot, may increase blood flow, which may indirectly enhance exercise 
performance.1–3 Previous studies on nitrate supplementation have resulted in enhanced exercise 
tolerance, mitochondrial efficiency, blood flow, oxygenation, and decreased muscular soreness, 
blood pressure, blood lactate, and oxygen uptake.2,4–7 The ergogenic effect from nitrate 
supplementation has been linked to enhanced vasodilation, reducing vascular resistance, and 
increasing blood flow to working skeletal muscle.8 The natural components of pomegranate and 
beetroot, including nitrate and polyphenols, may be of additional benefit for endothelial function. 
Polyphenols have been shown to modulate oxidative stress, inflammation, improve endothelial 
function, have vasodilatory effects, and promote nitric oxide (NO) production, which may be 
beneficial for increasing blood flow.9–11 Polyphenols specific to pomegranate, including 
flavonols, ellagitannins, and anthocyanins have demonstrated a significant positive effect on 
endothelial-dependent vasodilation, more so than other fruits containing polyphenols.12,13 When 
comparing pomegranate juice and pomegranate extract (PE), both were effective in reducing 
platelet activation for better endothelial function, but PE reduced platelet activation to a better 
extent and was a more powerful antioxidant. Additionally, the concentration of PE 
supplementation was effective at an amount possible to obtain in polyphenol-rich food.13   
Several studies have examined different sources of nitrate supplementation to augment 
blood flow including L-arginine, L-citrulline, beetroot, and pomegranate. There are several 
1  
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pathways by which blood flow is increased to deliver oxygen and substrates to meet the demands 
of exercise, and NO has been recognized as an important factor in endothelial vascular relaxation 
during exercise.14,15 Through the nitric oxide synthase (NOS)-independent pathway, nitrate and 
nitrite are reduced to form NO, whereas in the NOS-dependent pathway, the amino acid L-
arginine is catalyzed by NOS enzymes to produce NO.16 The NOS-dependent pathway is 
dependent on oxygen where the nitrate-nitrite NOS-independent pathway is initiated in an 
anaerobic environment.17 Consuming PE acutely may improve high-intensity exercise and 
anaerobic exercise by increasing NO levels and concomitantly improving NOS efficiency to 
increase blood flow.5,16  
Changes in blood flow, blood pressure, vessel dilation, and oxygen uptake during 
exercise are important factors in order to meet the demands of exercise; consuming PE may help 
improve efficiency for exercise.18,19 Previous research has examined the effects of PE on blood 
pressure, demonstrating a significant reduction in systolic blood pressure, after one year of 
consumption.5 However, systolic and diastolic blood pressure were both reduced significantly 
after two weeks of consumption but there was no change in flow-mediated dilation (FMD).20 In 
contrast, acute ingestion of 1000mg of PE resulted in a significant increase in blood flow 30 min 
post ingestion and post exercise.4 In addition to the nitrate component of PE, polyphenols have 
been shown to reduce systolic blood pressure and enhance FMD.  Barona et al.9 investigated a 
30-day supplementation of grape polyphenol powder in individuals with metabolic syndrome 
that resulted in a reduction in systolic blood pressure and an increase in FMD.21 Conversely, 
there were no differences in blood pressure or FMD when 30 participants with high cholesterol 
ingested either polyphenol-rich or polyphenol-poor apples for four weeks.22 While these studies 
examined chronic intake, acute ingestion of 600 mg of cranberry and grape seed polyphenol 
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extract in elite athletes resulted in increased FMD after consuming the polyphenol-rich drink 30, 
60, 90, and 120 minutes with FMD peaking at 60 minutes and returning to baseline 3 hours after 
ingenstion.23 This data supports ingestion of a natural nitrate and polyphenol source, such as PE 
acutely, may be beneficial for increasing blood flow. 
By increasing blood flow, there may be an increase in oxygen and nutrients delivery to 
working skeletal muscle, potentially aiding in exercise performance and augmenting exercise 
recovery.24 Tombold et al.3 demonstrated attenuated weakness and reduced soreness at the elbow 
flexor muscles when consuming PE for 15 days before performing eccentric exercise. After an 
acute ingestion of PE, Trexler et al.4 demonstrated an increased time to exhaustion during high-
intensity running. In contrast, while the NOS-independent pathway suggests an improvement in 
anaerobic capacity, little research has been done to examine the effects of PE on enhancing this 
pathway during exercise. Additional research evaluating the effects of PE on blood pressure and 
FMD could be beneficial for enhancing high-intensity exercise. 
Previous research indicates PE is beneficial when consumed chronically,3,25 however, 
data also suggests PE may be beneficial to exercise when ingested acutely4 due to the high nitrate 
and polyphenol concentrations. Additional research investigating the effects of PE on anaerobic 
exercise would be beneficial for aiding athletes in their training by the use of a natural compound 
to enhance blood flow and performance in an anaerobic setting. Therefore, this study aimed to 
determine if PE supplementation is beneficial when ingested acutely for anaerobic exercise, 
FMD, oxygen saturation, heart rate and blood pressure. 
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PURPOSE 
1. The primary purpose of this study was to examine the acute effects of pomegranate 
extract on anaerobic exercise. 
2. The secondary purpose of this study was to evaluate the acute effects of pomegranate 
extract on cardiovascular responses of: FMD, heart rate, blood pressure, and oxygen 
saturation. 
 
RESEARCH QUESTIONS 
1. Did pomegranate extract have an acute effect on peak power output, repeated sprint 
ability, and repetitions to fatigue? 
2. Did pomegranate extract have an acute effect on FMD, heart rate, blood pressure, and 
oxygen saturation? 
 
RESEARCH HYPOTHESES 
1. Pomegranate extract will increase peak power output and average power in the sixth 
through tenth sprint. 
2. Pomegranate extract will increase repetitions to fatigue. 
3. Pomegranate extract will increase blood flow 30 min post-ingestion, immediately post, 
and 30 minutes post exercise of repetitions to fatigue and the repeated sprint ability test 
when compared to placebo. 
4. Pomegranate extract will increase vessel diameter 30 min post-ingestion, immediately 
post, and 30 minutes post exercise of repetitions to fatigue and the repeated sprint ability 
test when compared to placebo. 
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5. Pomegranate extract will decrease blood pressure 30 minutes post exercise of repetitions 
to fatigue and the repeated sprint ability test when compared to placebo. 
6. Pomegranate extract will increase oxygen saturation immediately post and 30 minutes 
post exercise of repetitions to fatigue and the repeated sprint ability test when compared 
to placebo. 
7. Pomegranate extract will have no effect on heart rate. 
 
DELIMITATIONS 
1. Nineteen resistance trained males and females, defined as regularly participating in a 
resistance training program for at least three days a week for the past three months, were 
recruited to participate in this study. 
2. Participants were between the ages of 18-35 years. 
3. Participants were excluded if using or had used dietary supplements of beta-alanine, 
creatine, carnosine, or taurine within 12 weeks prior to enrollment. 
4. Participants were fasted three hours prior to testing sessions, euhydrated, and did not 
consume nitrates 12 hours prior to test period. 
5. This study consisted of five visits to the Applied Physiology Lab. 
6. Blood flow was measured using an ultrasound. 
7. Oxygen saturation was measured using a pulse oximeter. 
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LIMITATIONS 
1. Participant recruitment occurred at numerous departments on the University of North 
Carolina campus and through physical activity and exercise and sport science classes at 
UNC. Therefore participant selection was not truly random. 
2. Due to the delimitations of resistance trained individuals and age, the results may not be 
generalized to other training modalities or individuals outside the age range that were be 
tested. 
ASSUMPTIONS 
Theoretical 
1. Participants accurately provided health and exercise history on the enrollment 
questionnaire. 
2. Participants accurately provided food intake information on the dietary log. 
3. Participants followed pre-testing dietary and exercise guidelines.  
4. Participants continued regular nutrition habits while participating in the study.  
Statistical 
1. The population from which the sample was drawn was normally distributed. 
2. The variability was approximately equal in the selected sample (homogeneity of 
variance). 
 
DEFINITIONS OF TERMS 
Resistance Trained – regularly participated in a resistance training program for at least three days 
a week for the past three months as determined by a health and exercise status questionnaire. 
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Anaerobic Exercise – type of exercise that is high intensity and shorter in duration as in sprinting 
and strength-based exercise. This is the type of exercise performed in the repetitions to fatigue 
and repeated sprint ability tests. 
 
Repetitions to Fatigue – an exercise routine that included completing one set of bench press and 
one set of leg press at 80% of 1RM to failure.  
 
Repeated Sprint Ability – an exercise routine that included a warm-up, ten six-second maximal 
sprints with a load of 65 g/kg of body weight with 30 seconds of passive recovery between 
sprints, and a cool-down period. 
 
Pomegranate Extract (PE)– 1000mg of pomegranate extract (True Pomegranate Extract, Stiebs 
Nature Elevated, Madera, CA) in capsule form. 
 
Flow-mediated dilation – measurement from an ultrasound that determined brachial artery blood 
flow and vessel diameter. 
 
SIGNIFICANCE OF STUDY 
 This study examined the effects of pomegranate extract on anaerobic exercise through 
repeated sprint ability and repetitions to fatigue, FMD, heart rate, blood pressure, and oxygen 
saturation. Previous research has shown benefits of pomegranate extract as an ergogenic aid 
when consumed acutely, due to the natural components of nitrates and polyphenols. Previous 
research has also shown benefits of pomegranate extract to improve endothelial function in 
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clinical settings. To date, no research has examined the ergogenic effects of pomegranate extract 
on anaerobic performance, or looked at the effects of pomegranate extract on cardiovascular 
measures before and after resistance exercise. The results of this study may extend the use of a 
natural compound to enhance blood flow and exercise performance in an anaerobic setting. 
Therefore, this study may be beneficial for athletes, and as well as in clinical settings, to improve 
endothelial function. 
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CHAPTER II 
REVIEW OF LITERATURE 
 
INTRODUCTION 
 
Data evaluating the effects of pomegranate extract (PE) on resistance training and 
anaerobic exercise are limited. Several studies have examined the effects of augmenting the 
nitric oxide synthesis (NOS) pathway using L-arginine, L-citrulline, and beetroot on exercise,26–
30 but few have examined the effects of PE, high in nitrate and polyphenols, on exercise 
performance, blood flow, and blood pressure (BP). 3,4 As a result, the aim of this study was to 
examine the effects of PE on anaerobic exercise, FMD, heart rate, BP, and oxygen saturation. 
Previous studies on supplements that contain nitrate have resulted in enhanced exercise 
tolerance, mitochondrial efficiency, blood flow, oxygenation, and decreased muscular soreness, 
BP, blood lactate, and oxygen uptake.2,4–7 Indirect ergogenic effects are likely a result of 
enhanced vasodilation, reduced vascular resistance, and increased blood flow. By increasing 
blood flow, there may be an increase in oxygen and nutrient delivery to working skeletal muscle, 
suggesting enhanced exercise performance and exercise recovery.24 During exercise, NO has 
been recognized as an important factor in endothelial vascular relaxation.14,15 In the NOS-
dependent pathway, the amino acid L-arginine is catalyzed by NOS enzymes to L-citrulline to 
produce NO.16 Several studies have investigated the effects of arginine and citrulline 
supplements on exercise performance due to their importance to the NOS-dependent pathways 
with equivocal results on enhancing exercise performance.16 In the NOS-independent pathway, 
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nitrate and nitrite are reduced to form NO.16,17 Sources of dietary nitrate have been investigated 
on enhancing exercise performance including beetroot juice and pomegranate. Beetroot juice has 
been demonstrated to be effective for improving endurance exercise, oxygen kinetics,2 and time 
to exhaustion30 when consumed chronically, but not acutely.29 Pomegranate extract has been 
suggested to be beneficial for endothelial vascular relaxation at rest and during exercise,31 due to 
high levels of nitrate and antioxidants, specifically polyphenols. Pomegranate is high in 
polyphenols, specifically, flavonols, ellagitannins, and anthocyanins, which have been 
demonstrated to be more effective in endothelial-dependent vasodilation than other fruits 
containing polyphenols.12,13 Polyphenols also may be beneficial for vessel dilation and increasing 
blood flow due to the anti-inflammatory and hypolipidemic effects,9,10 and have been previously 
demonstrated to modulate oxidative stress, inflammation, improve endothelial function, have 
vasodilatory effects, and promote NO production.9–11  
As vessel diameter increases from endothelial vascular relaxation, BP decreases and 
blood flow increases.14 Flow-mediated dilation (FMD) is a non-invasive measure to assess 
endothelium function and blood flow, and is proposed to reflect the bioavailability of NO 
because vessel dilation is mediated by NO.32 Understanding the mechanisms for pomegranate 
increasing NO levels to indirectly enhance exercise performance may be beneficial for athletes, 
and as well as in clinical settings, to improve endothelial function. This literature review will 
discuss the current research in regards to ingredients that increase NO levels: L-arginine, L-
citrulline, beetroot, polyphenols and pomegranate. 
 
	   11 
L-ARGININE AND L-CITRULLINE 
Several studies have investigated the effects of arginine and citrulline ingredients on 
exercise performance due to their importance to the NOS-dependent pathway, reporting 
equivocal results on enhancing exercise performance. When combining L-arginine 
supplementation with other components, studies have demonstrated an increase in exercise 
performance in untrained or moderately trained individulas,16 but no beneficial effects for trained 
individuals and athletes have been reported.33 Bailey et al.34 examined an acute 20 g dose of a 
supplement containing 6 g L-arginine and trace amounts of vitamins E, C, B6, and B12, and an 
amino acids mix. In a low to moderate bout of exercise, there was a decrease in oxygen 
consumption and an increase in time to exhaustion in an incremental cycling test. Similarly, 
Chen et al.35 demonstrated an increased power output in a cycle test to exhaustion when 
supplementing with 5.2 grams of L-arginine and L-citrulline, and antioxidants for 21 days. In 
contrast, Colombani et al.33 exhibited no metabolic or performance benefits in a marathon run 
following 14 days of L-arginine supplementation in endurance-trained runners. As these studies 
are examining L-arginine with a combination of other ingredients, the resulting ergogenic effects 
could be due to other mechanisms, and not related to NO synthesis. 
 Through the NOS-dependent pathway, L-citrulline is an important precursor of L-
arginine to produce NO, but has not been demonstrated to enhance performance. Sureda et al.36 
demonstrated an increase in plasma arginine availability to increase NO synthesis when 
supplemented with L-citrulline-malate, but NO was not measured directly. Hickner et al.37 
investigated an acute ingestion of L-citrulline before an incremental treadmill test to exhaustion 
and saw a detriment to exercise performance when compared to the placebo. When examining L-
citrulline in combination with malate, an intermediate component of the Krebs Cycle,16 studies 
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have resulted in an increase in NO metabolites36 and increased rate of ATP production during 
exercise,38 but did not increase exercise performance. As a result, there is not sufficient data or 
evidence exhibiting L-arginine and L-citrulline, alone, to enhance exercise performance. 
 
BEETROOT JUICE 
 Beetroot juice is a common source of dietary nitrate and has been studied for chronic 
consumption for enhancing endurance exercise. Beetroot juice ingestion has been shown to 
significantly augment plasma nitrate concentrations, in comparison to a placebo, likely 
improving endothelial function.29 In overweight and obese men, FMD was improved and plasma 
concentrations of NO were higher after consuming 140ml of beetroot juice containing 500 mg of 
nitrate.39 Christensen et al.40 also exhibited higher plasma nitrate and nitrite levels after 
consuming beetroot for four and six days when compared to a placebo; but there were no 
differences in oxygen kinetics, time-trial performance, peak power output during an endurance 
cycle test, or repeated sprint capacity in highly trained cyclists. In contrast, Bailey et al.2 
exhibited an increase in time to exhaustion and reduced oxygen cost at a fixed submaximal work 
rate when beetroot was consumed for six days. Likewise, significant improvements in 10-km 
time trial performance in trained cyclists were exhibited after six days of consuming nitrate-rich 
beetroot juice.30 In agreement, 500ml beetroot juice ingestion for six days in well-trained rowers 
improved maximal 500meter ergometer rowing repetitions, but there was no difference in 
oxygen saturation or blood lactate when compared to placebo.41 When recreationally active 
individuals consumed 500ml of beetroot juice for seven days, exercise tolerance was improved at 
60%, 70%, and 80% of peak power, but there was no significant change in 100% peak power or 
critical power during severe-intensity cycling exercise.42 This suggests an increased exercise 
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performance for endurance exercise, as opposed to high-intensity exercise, when consuming 
beetroot juice for six-seven days. 
When examining acute consumption (1 dose) of beetroot, 4-km and 16.1-km cycling 
performance, and mean power output was improved significantly, but there was no difference in 
oxygen uptake after ingesting 500ml two and a half hours prior to exercise.43 After consuming 
200 grams (>500 mg of nitrate) of whole beetroot 75 minutes before a 5-km treadmill time trial, 
running velocity was faster when compared to a placebo of cranberry relish.26 Conversely, 
twenty trained male cyclists ingested 140 ml of concentrated beetroot juice 2.5 hours before 
completing a 1-hour cycling time trial.29 There were no significant differences between beetroot 
and placebo on time-trial performance, power output, or heart rate. In agreement, 500ml of 
beetroot consumed 2.5 hours before a 50-mile cycling time trial did not significantly improve 
performance in well-trained cyclists.44 Muggeridge et al.28 also failed to demonstrate a 
significant difference between 70ml beetroot and placebo for sprinting peak power or a 1-km 
kayak time trial. However, there was lower oxygen consumption when kayaking at 60% steady 
state effort after consuming beetroot. This suggests beetroot may enhance endurance exercise, 
but not anaerobic exercise. As a result, the effects of beetroot on exercise performance favor 
chronic consumption for endurance exercise, and acute consumption of beetroot is unclear for 
enhancing exercise performance. 
 
POLYPHENOLS 
Polyphenols, naturally existing antioxidants in plants and plant products, have also been 
demonstrated to modulate oxidative stress, inflammation, improve endothelial function, have 
vasodilatory effects, and promote NO production.9–11 Specific polyphenols from pomegranate, 
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flavonols, ellagitannins, and anthocyanins, have been shown to be effective for inducing              
endothelial-dependent vasodilation.12,13 Looking at polyphenol sources, Barona et al.9 
investigated a 30-day supplementation of grape polyphenol powder in participants with 
metabolic syndrome, resulting in a reduction in systolic BP, an increase in FMD, but there was 
no change in plasma nitrite and nitrate to estimate NO production. Similarly in a cross over study, 
19 hypertensive participants ingested 100 g of either flavanol-rich dark chocolate containing 
1000mg of polyphenols or flavanol-free white chocolate for 15 days. After the flavanol-rich dark 
chocolate intervention, systolic and diastolic BP decreased and FMD increased when compared 
to the flavanol-free white chocolate.21 Conversely in a cross over study, there were no 
differences in BP or FMD when 30 participants with high cholesterol ingested either polyphenol-
rich or polyphenol-poor lyophilized apples for four weeks. Van Mierlo et al.32 also found no 
significant differences in FMD and BP measured after a two week treatment period where 
healthy males consumed capsules containing either a wine grape mix or grape seed, both 
containing 800 mg of polyphenols or placebo.  
While these studies examined chronic intake, acute ingestion of 600 mg of cranberry and 
grape seed polyphenol extract in elite athletes resulted with increased FMD 30, 60, 90, and 120 
minutes after consuming the polyphenol-rich drink, with FMD peaking at 60 minutes and 
returning to baseline 3 hours after ingestion. In the same study, 800 mg polyphenol extract from 
cranberries and grape seed was ingested 60 minutes before a 3-km time trial cycle test in elite 
athletes, with no significant differences in time to completion, average wattage, or perceived 
exertion after the time trial between the placebo and the polyphenol-rich drink. Yet, the athletes 
had lower plasma lactate levels before, immediately following, and 2.5 minutes post recovery of 
the test, and heart rate was significantly lower 2 minutes and 5 minutes post exercise.23 Also 
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examining polyphenols and exercise, Connolly et al.45 investigated consumption of tart cherry 
juice, containing high antioxidant concentrations, for 8 days on the symptoms of muscle damage, 
demonstrating maintenance in strength, and reduction in pain following a muscle damage bout, 
when compared to a placebo.  
The data on polyphenols and exercise performance, FMD, BP, and NO synthesis are 
limited, but demonstrate some favorable effects for improving blood flow and decreasing BP, 
blood lactate, and muscle strength loss and pain. These effects may indirectly enhance exercise 
performance.  
 
POMEGRANATE 
The effects of natural nitrate and polyphenols in pomegranate extract may be beneficial 
for exercise when consumed acutely, as blood flow is considered a limiting factor in muscle 
oxygenation during high intensity exercise.23 To date, there is little data investigating PE on 
exercise performance. Comparing pomegranate juice and PE with the same polyphenolic 
constitute of the juice, both were effective in reducing platelet activation for improved 
endothelial function, but PE reduced platelet activation at a lower concentration than the juice (2 
µM vs. 20 µM). Additionally, the effective amount of PE was equivalent to that obtained from 
polyphenol-rich foods or a moderate consumption of pomegranate juice.13 Examining PE and 
exercise performance, highly active males and females participated in a crossover study where 
either 1000mg of PE or placebo was consumed 30 minutes prior to exercise. Time to exhaustion 
significantly improved after ingesting PE at 90% and 100% of peak velocity, but not 110% of 
peak velocity when compared to placebo. Blood flow also significantly increased 30 minutes 
post ingestion of PE, and vessel diameter was significantly enhanced 30 minutes post exercise.4 
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Trombold et al.3 examined the effects of consuming 250 ml of pomegranate juice 
supplementation for 15 days on eccentric exercise at the elbow and knee muscles. After the 
supplementation period, participants completed a muscle damage bout, and then tested muscle 
soreness, maximal isometric elbow flexion strength, and maximal knee extension strength. The 
pomegranate juice supplementation attenuated weakness and reduced soreness at the elbow 
flexor muscles, but did not do so at the knee extensor muscles. Although there is little research 
on PE and exercise performance, the NOS-independent pathway suggests ingesting PE acutely 
before exercise may increase NO and improve blood flow to indirectly enhance performance. 
The previous research also supports the mechanism by which PE may enhance performance. 
Additionally, PE has been demonstrated to be beneficial for improving endothelial 
function in clinical populations when consumed chronically. Twenty-one hypertensive 
participants consumed either 150ml daily of pomegranate juice or water for two weeks. In the 
pomegranate juice group, systolic and diastolic BP were significantly reduced, but there was no 
difference in FMD.20 Similarly, patients with carotid artery atherosclerosis consumed either 50ml 
of pomegranate juice or were placed in a control group for one year. In the pomegranate juice 
group, systolic BP was reduced by 21%, but diastolic BP did not decrease.25 In patients with 
coronary heart disease and myocardial ischemia, pomegranate juice of 240ml or placebo was 
consumed daily for three months. After the three month supplementation, stress-induced 
ischemia decreased significantly in pomegranate juice group, but increased in the control 
group.46 As a result, PE may be beneficial for cardiovascular health in clinical populations, but 
more research needs to be completed with acute consumption of PE. 
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CONCLUSION 
 When examining endogenous ingredients that increase NO concentrations, several studies 
have been completed on L-arginine, L-citrulline and beetroot, but additional research should 
investigate the effects of pomegranate and polyphenols on exercise performance. While 
supplementation of L-arginine and L-citrulline have previously been shown to increase plasma 
arginine for NO synthesis, supplementation has not been favorable for enhancing exercise 
performance. Beetroot, a natural source of nitrate, has resulted in improvements in exercise 
performance when taken chronically, but there is not strong evidence for acute supplementation 
or for anaerobic exercise. Though beetroot has high levels of nitrate, it contains different 
subtypes of polyphenols than pomegranate. The polyphenols in pomegranate, flavonols, 
ellagitannins, and anthocyanins, have been demonstrated to be more effective in endothelial-
dependent vasodilation than other fruits containing polyphenols.12,13 Polyphenols have 
demonstrated a decrease in blood lactate, muscle strength loss and pain, and an increase in blood 
flow when consumed acutely, which may indirectly enhance exercise performance. Given that 
pomegranate has high levels of polyphenols, as well as high concentrations of nitrate, ingesting 
pomegranate may be beneficial for enhancing anaerobic exercise. By increasing blood flow, 
there may be an increase in oxygen and nutrient delivery to working skeletal muscle, potentially 
aiding in exercise performance and enhancing exercise recovery. Therefore, this study aims to 
determine if PE supplementation is beneficial when ingested acutely for anaerobic exercise, 
FMD, heart rate, oxygen saturation, and blood pressure in healthy adults. 
 
 
 
 
 
 
	   18 
 
 
 
 
CHAPTER III 
METHODOLOGY 
EXPERIMENTAL DESIGN 
In a double blind crossover design, participants were randomly assigned, via random 
allocation software, to pomegranate extract (PE) or placebo (PL).  Five separate visits to the 
laboratory were completed (Figure 1); the first visit consisted of a series of baseline assessments 
including height, weight, and maximal upper and lower-body strength. For visits 2-5, participants 
rested 10 minutes then completed resting cardiovascular measurements of flow mediated dilation 
(FMD), blood pressure (BP), heart rate (HR), and oxygen saturation (SP02). After baseline tests, 
participants ingested their assigned supplement, PE or PL, in random order. Resting 
cardiovascular measurements were taken on all visits at baseline, at 30 minutes post-ingestion 
(30minPI), immediately post exercise (IPost), and 30 minutes post exercise (30minPostEx). The 
exercise session in visit 2 consisted of a repeated sprint ability (RSA) test on a cycle ergometer. 
The exercise session in visit 3 consisted of repetitions to fatigue (RTF) calculated at 80% of 
upper and lower-body maximal strength that was tested in the first visit. Exercise sessions were 
performed at the same time of day (+/- 2hours), with at least 24 hours between same treatment 
visits (visits 2 and 3; visits 4 and 5), and at least a week between different treatment conditions. 
Visits four and five were identical to visits 2 and 3, with the opposite treatment.  
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PARTICIPANTS 
Nineteen (8 male, 11 female) resistance-trained individuals (mean ± SD; age: 22.1 ± 1.9 
yrs; height: 170.4 ± 12.4 cm; weight: 68.7 ± 15.9 kg) between the ages of 18-35 years 
participated in this study. All participants were recreationally active, participating in at least 
three hours per week of resistance training for at least three months, determined by an exercise 
status questionnaire. All methodology was approved by the University’s Institutional Review 
Board and all subjects provided written informed consent prior to participation. 
 
SUPPLEMENTATION 
Using a computer generated allocation sequence, in a double-blind fashion, participants 
were randomized to either 1000mg of pomegranate extract (PE; True Pomegranate Extract, 
Stiebs Nature Elevated, Madera, CA) or placebo (PL; 95% maltodextrin, 5% purple carrot and 
hibiscus for color). Capsules were blinded in identical opaque capsules, and were ingested in the 
lab with 6 oz of water. After ingestion, participants rested 30 minutes before beginning the 
exercise test.  
 
CARDIOVASCULAR MEASUREMENTS 
Resting cardiovascular measurements were taken on all visits at baseline, 30minPI, IPost, 
and 30minPostEx. Heart rate was measured using a Polar heart rate monitor (Polar FT1, Polar 
USA, Port Washington, NY, USA). Oxygen saturation (SPO2) was measured using a pulse 
oximeter (Contec Medical Systems Co, Qinhuangdao, China). Blood pressure was measured 
with an automatic blood pressure cuff (Omron Healthcare, Lake Forest, IL, USA). For the 
measurements of blood flow and vessel diameter, FMD was measured using a GE logiq-e B-
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mode ultrasound (GE Healthcare, Wisconsin, USA) with vascular, pulse wave, and color flow 
settings. Blood flow was measured using modified protocol of Uehata et al.,47 using the brachial 
artery.4 For the resting measurements, a blood pressure cuff was placed on the upper arm for one 
minute inflated to 180 mmHg. The cuff was taken off and the ultrasound probe (GE: 12L-RS) 
was immediately placed longitudinally on the upper arm, 5-15 cm above the antecubital fossa, 
over the brachial artery to measure blood flow for at least four heart beats. Diameter of the artery 
was quantified using the ultrasound software ‘measure’ function by drawing a straight line 
between the walls of the artery.  Blood flow measurements IPost and 30minPostEx did not use 
the blood pressure cuff prior to the measurement. Reliability measures for blood flow produced 
an intraclass correlation coefficent (ICC) of 0.86 and standard error of the measurement (SEM) 
of 5.92 mL·min-1; reliability for vessel diameter resulted in an ICC of 0.82 and SEM of 0.027 cm. 
 
MAXIMAL STRENGTH 
Each participant performed a 1-repetition maximal (1RM) strength test for baseline 
upper- and lower-body strength on bench press and leg press (York Barbell Co., York, PA). 
Participants completed a self-selected warm-up for five minutes and were familiarized with the 
equipment. Each participant then performed 8-10 repetitions at 50% of their predicted 1RM. 
After a 1-minute rest period, participants then performed 4-6 repetitions at 80% of their predicted 
1RM. Following a 1-minute rest period, the weight was increased to the estimated 1RM load, 
and participants attempted to lift the weight one time. After each successful attempt of one 
repetition, the weight was increased until a failed attempt occurred. Two to three minutes of rest 
was given between each 1RM attempt, and the 1RM was found within five attempts to avoid 
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fatigue. The heaviest weight successfully lifted was recorded as the 1RM. After testing maximal 
strength, participants were familiarized with the RSA protocol. 
 
REPEATED SPRINT ABILITY (RSA)  
Peak anaerobic power and anaerobic capacity were assessed using a RSA protocol on a 
friction-loaded cycle ergometer (Monark 894E, Stockholm, Sweden). Participants warmed up on 
the cycle for ten minutes at a self-selected pace prior to performing the RSA. The RSA consisted 
of ten six-second maximal sprints with 30 seconds of passive recovery between each sprint. The 
load applied on the cycle ergometer was 65 g/kg of body weight for each participant.48 
Participants were encouraged verbally during each maximal sprint, and remained seated on the 
cycle ergometer during the entire test. 
 
REPETITIONS TO FATIGUE (RTF) 
 The results from the 1RM assessments were used to determine the weight load for each 
participant for the RTF sessions. The exercises were performed in order of: bench press then leg 
press (York Barbell Co., York PA). Following a self-selected warm-up, one set at 80% of 1RM 
was completed to fatigue on bench press and leg press, respectively, with three minutes of rest 
between each exercise.49 Heart rate, FMD, SPO2, and BP were assessed at baseline, 30minPI, 
immediately post bench press (IPostBench), immediately post leg press (IPostLeg), and 
30minPostEx. 
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STATISTICAL ANALYSIS 
 Data was analyzed using one-way ANOVAs for bench and leg press repetitions. Separate 
two-way mixed factorial ANOVA models [treatment (PE vs. PL) × time (sprint 1 vs. sprint 2 … 
vs. sprint 10)] to assess peak power output and average power. Separate two-way mixed factorial 
ANOVA models [treatment (PE vs. PL) × time (baseline vs. 30minPI vs. IPost vs. 
30minPostEx)] to assess blood flow, BP, HR, and SPO2, with Bonferroni post hoc comparisons 
for the RSA tests. For vessel diameter in the RSA test, a linear-mixed model ANCOVA was 
employed to covary for significant differences at baseline. For the RTF tests, separate two-way 
mixed factorial ANOVA models [treatment (PE vs. PL) × time (baseline vs. 30minPI vs. IPost vs. 
30minPostEx)] were used to assess FMD, BP, HR, and SPO2, with Bonferroni post hoc 
comparisons for bench press and leg press. Change scores from PE to PL were calculated for 
each participant and 95% confidence intervals (CI) were placed around the mean change score. If 
the 95% CI included zero, the mean change score was not different from zero, which can be 
interpreted as no statistical change. If the 95% CI interval did not include zero, the mean change 
score was considered statistically significant (p ≤ 0.05). SPSS Version 20 (IBM; Chicago, IL) 
was used to perform the ANOVA models and ANCOVA with an alpha level of p<0.05 for 
statistical significance. The 95% CI were created and calculated in Microsoft Excel (Version 
2008, Microsoft Corporation; The Microsoft Network, LLC, Richmond, WA). 
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CHAPTER IV 
MANUSCRIPT 
INTRODUCTION 
 
The popularity of pre-workout supplements and ingredients has grown tremendously over 
the last decade, specifically ingredients thought to increase nitrate concentration, such as arginine 
and citrulline.50 Recently more natural ingredients, such as pomegranate and beetroot, have been 
shown to increase nitrate concentration vis-à-vis the nitric oxide synthase (NOS)-independent 
pathway.16 Nitric oxide (NO) has been recognized as an important factor in endothelial vascular 
relaxation during exercise.14,15 Through the NOS-independent pathway, nitrate and nitrite are 
reduced to form NO, whereas in the NOS-dependent pathway, the amino acid L-arginine is 
catalyzed by NOS enzymes to produce NO.51 The ergogenic effect from nitrate supplementation, 
and its derivatives, have been linked to enhanced vasodilation, reducing vascular resistance, and 
increasing blood flow to working skeletal muscle.4,8,52 Several studies have investigated the 
effects of arginine and citrulline ingredients on exercise performance due to their importance in 
the NOS-dependent pathway, reporting equivocal results on enhancing exercise performance.16 
However, the natural components of pomegranate and beetroot, including nitrate and 
polyphenols, may be more effective, providing additional benefit for endothelial function. 
Polyphenols have been shown to modulate oxidative stress, decrease inflammation, improve 
endothelial function, stimulate vasodilation, and promote NO production, which may be 
beneficial for increasing blood flow and exercise performance.9–11 
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 Previous studies on nitrate supplementation have resulted in enhanced exercise tolerance, 
blood flow, oxygenation, and decreased blood pressure.2,4–7  Previous research has primarily 
examined the effects of beetroot on exercise performance, while few studies have examined 
pomegranate juice or pomegranate extract (PE). However, additional ergogenic benefit from PE 
may result from the high polyphenol content.12,13 Results from Bailey et al.,2 when using beetroot, 
demonstrated an increase in time to exhaustion and reduced oxygen cost at a fixed submaximal 
work rate. Similarly, exercise tolerance was improved at submaximal peak power workloads 
after consuming beetroot.42 Previous research on PE and exercise performance has demonstrated 
a delay in fatigue during high-intensity running and increased vessel diameter and blood flow.4 
Additional research evaluating the effects of PE on blood flow and vessel diameter could be 
beneficial for enhancing high-intensity or anaerobic exercise. 
In addition to the nitrate component of PE, polyphenols have been shown to reduce 
systolic blood pressure and enhance flow-mediated dilation (FMD).9 Polyphenol 
supplementation has had positive cardiovascular effects in men with metabolic syndrome9 and 
cardiovascular disease,11 but were not beneficial in healthy men.32 However, acute polyphenol 
consumption increased FMD and improved endothelial function in elite athletes.23 This data 
supports acute ingestion of a natural nitrate and polyphenol source, such as PE, may be 
beneficial for cardiovascular effects and exercise improvement.4,19 Further research examining 
the effects of PE on FMD and endothelial function in a healthy population is warranted. 
Earlier research has demonstrated a potential important role of dietary nitrate, when 
converted to NO, under periods of low oxygen availability/exercising state50 and as a result may 
be beneficial for anaerobic exercise. Additional research investigating the effects of PE on 
anaerobic exercise and resistance training would be beneficial for potentially aiding athletes in 
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their training by the use of a natural compound to enhance blood flow and performance. 
Therefore, this study aimed to evaluate the effects of acute PE supplementation on anaerobic 
exercise, FMD, oxygen saturation, heart rate and blood pressure in healthy men and women. 
METHODS 
Experimental Design 
In a double blind crossover design, participants were randomly assigned, via random 
allocation software, to pomegranate extract (PE) or placebo (PL) groups.  Five separate visits to 
the laboratory were completed (Figure 1); the first visit consisted of a series of baseline 
assessments including height, weight, and maximal upper and lower-body strength. For visits 2-5, 
participants rested 10 minutes then completed resting cardiovascular measurements of blood 
pressure (BP), heart rate (HR), oxygen saturation (SP02), and flow mediated dilation (FMD). 
After baseline tests, participants ingested their assigned supplement, PE or PL, in random order. 
Resting cardiovascular measurements were taken on all visits at baseline, at 30 minutes post-
ingestion (30minPI), immediately post exercise (IPost), and 30 minutes post exercise 
(30minPostEx). The exercise session in visit 2 consisted of a repeated sprint ability (RSA) test on 
a cycle ergometer. The visit 3 exercise session consisted of repetitions to fatigue (RTF) 
calculated at 80% of upper and lower-body maximal strength that was tested in the first visit. 
Exercise sessions were performed at the same time of day (+/- 2hours), with at least 24 hours 
between same treatment visits (visits 2 and 3; visits 4 and 5), and at least a week between 
different treatment conditions. Visits four and five were identical to visits two and three, with the 
opposite treatment.  
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Participants 
Nineteen (8 male, 11 female) resistance-trained individuals (mean ± SD; age: 22.1 ± 1.9 
yrs; height: 170.4 ± 12.4 cm; weight: 68.7 ± 15.9 kg) between the ages of 18-35 years 
participated in this study. All participants were recreationally active, participating in at least 
three hours per week of resistance training for at least three months, determined by an exercise 
status questionnaire. All methodology was approved by the University’s Institutional Review 
Board and all subjects provided written informed consent prior to participation. 
Supplementation 
Using a computer generated allocation sequence, in a double-blind fashion, participants 
were randomized to either 1000mg of pomegranate extract (PE; True Pomegranate Extract 
[Nitro2Granit], Stiebs Nature Elevated, Madera, CA) or placebo (PL; 95% maltodextrin, 5% 
purple carrot and hibiscus for color). Capsules were blinded in identical opaque capsules, and 
were ingested in the lab with 6 oz of water. After ingestion, participants rested 30 minutes before 
beginning the exercise test.  
Cardiovascular Measurements 
Resting cardiovascular measurements were taken on all visits at baseline, 30minPI, IPost, 
and 30minPostEx. Heart rate was measured using a Polar heart rate monitor (Polar FT1, Polar 
USA, Port Washington, NY, USA). Oxygen saturation (SPO2) was measured using a pulse 
oximeter (Contec Medical Systems Co, Qinhuangdao, China). Blood pressure was measured 
with an automatic blood pressure cuff (Omron Healthcare, Lake Forest, IL, USA). For the 
measurements of blood flow and vessel diameter, FMD was measured using a GE logiq-e B-
mode ultrasound (GE Healthcare, Wisconsin, USA) with vascular, pulse wave, and color flow 
settings. Blood flow was measured using modified protocol of Uehata et al.,47 using the brachial 
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artery.4 For the resting measurements, a blood pressure cuff was placed on the upper arm for one 
minute inflated to 180 mmHg. The cuff was taken off and the ultrasound probe (GE: 12L-RS) 
was immediately placed longitudinally on the upper arm, 5-15 cm above the antecubital fossa, 
over the brachial artery to measure blood flow for at least four heartbeats. Diameter of the artery 
was quantified using the ultrasound software ‘measure’ function by drawing a straight line 
between the walls of the artery.  Blood flow measurements IPost and 30minPostEx did not use 
the blood pressure cuff prior to the measurement. Reliability measures for blood flow produced 
an intraclass correlation coefficent (ICC) of 0.86 and standard error of the measurement (SEM) 
of 5.92 mL·min-1; reliability for vessel diameter resulted in an ICC of 0.82 and SEM of 0.027 cm. 
Maximal Strength 
Each participant performed a 1-repetition maximal (1RM) strength test for baseline 
upper- and lower-body strength on bench press and leg press (York Barbell Co., York, PA). 
Participants completed a self-selected warm-up for five minutes and were familiarized with the 
equipment. Each participant then performed 8-10 repetitions at 50% of their predicted 1RM. 
After a 1-minute rest period, participants then performed 4-6 repetitions at 80% of their predicted 
1RM. Following a 1-minute rest period, the weight was increased to the estimated 1RM load, 
and participants attempted to lift the weight one time. After each successful attempt of one 
repetition, the weight was increased until a failed attempt occurred. Two to three minutes of rest 
was given between each 1RM attempt, and the 1RM was found within five attempts to avoid 
fatigue. The heaviest weight successfully lifted was recorded as the 1RM. After testing maximal 
strength, participants were familiarized with the RSA protocol. 
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Repeated Sprint Ability (RSA) 
Peak anaerobic power and anaerobic capacity were assessed using a RSA protocol on a 
friction-loaded cycle ergometer (Monark 894E, Stockholm, Sweden). Participants warmed up on 
the cycle for ten minutes at a self-selected pace prior to performing the RSA. The RSA consisted 
of ten six-second maximal sprints with 30 seconds of passive recovery between each sprint. The 
load applied on the cycle ergometer was 65 g/kg of body weight for each participant.48 
Participants were encouraged verbally during each maximal sprint, and remained seated on the 
cycle ergometer during the entire test. 
Repetitions to Fatigue (RTF) 
The results from the 1RM assessments were used to determine the weight load for each 
participant for the RTF sessions. The exercises were performed in order of: bench press then leg 
press (York Barbell Co., York PA). Following a self-selected warm-up, one set at 80% of 1RM 
was completed to fatigue on bench press and leg press, respectively, with three minutes of rest 
between each exercise.49 Heart rate, FMD, SPO2, and BP were assessed at baseline, 30minPI, 
immediately post bench press (IPostBench), immediately post leg press (IPostLeg), and 
30minPostEx. 
Statistical Analysis 
Data was analyzed using one-way ANOVAs for bench and leg press repetitions. Separate 
two-way mixed factorial ANOVA models [treatment (PE vs. PL) × time (sprint 1 vs. sprint 2 … 
vs. sprint 10)] to assess peak power output and average power. Separate two-way mixed factorial 
ANOVA models [treatment (PE vs. PL) × time (baseline vs. 30minPI vs. IPost vs. 
30minPostEx)] to assess blood flow, BP, HR, and SPO2, with Bonferroni post hoc comparisons 
for the RSA tests. For vessel diameter in the RSA test, a linear-mixed model ANCOVA was 
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employed to covary for significant differences at baseline. For the RTF tests, separate two-way 
mixed factorial ANOVA models [treatment (PE vs. PL) × time (baseline vs. 30minPI vs. IPost vs. 
30minPostEx)] were used to assess FMD, BP, HR, and SPO2, with Bonferroni post hoc 
comparisons for bench press and leg press. Change scores from PE to PL were calculated for 
each participant and 95% confidence intervals (CI) were placed around the mean change score. If 
the 95% CI included zero, the mean change score was not different from zero, which can be 
interpreted as no statistical change. If the 95% CI interval did not include zero, the mean change 
score was considered statistically significant (p ≤ 0.05). SPSS Version 20 (IBM; Chicago, IL) 
was used to perform the ANOVA models and ANCOVA with an alpha level of p<0.05 for 
statistical significance. The 95% CI were created and calculated in Microsoft Excel (Version 
2008, Microsoft Corporation; The Microsoft Network, LLC, Richmond, WA). 
 
RESULTS 
Repeated Sprint Ability (RSA) 
There was no significant two-way interaction (p=0.17) or main effect for treatment 
(p=0.37) for average power. There was a significant main effect for time (p< 0.0001) with sprint 
1 producing a significantly higher average power than sprints 3-10; sprint 2 higher than sprints 3-
10; sprint 3 higher than sprints 4-10; sprint 4 higher than sprints 7-9; sprint 5 higher than sprint 8. 
When 95% CI were used, average power was significantly higher in sprint 5 for the PE treatment, 
compared to PL. When analyzing peak power, there was no two-way interaction (p=0.37) or 
main effect for treatment (p=0.19). There was a significant main effect for time (p<0.0001) with 
sprint 1 yielding significantly greater peak power than sprints 4-10; sprint 2 greater than sprints 8 
and 10; sprint 3 greater than sprints 7-10; sprint 4 greater than sprints 7-10; sprint 5 greater than 
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sprint 8. Peak power was significantly higher for sprint number 5 when supplementing with PE 
versus PL (mean difference [MD]= 31.81 Watts; p=0.046) and sprint 7 trended towards 
significance (MD= 35.34 Watts; p= 0.063). When 95% CI were employed, sprints 5 and 7 were 
significantly higher when PE was consumed (Figure 2).  
For vessel diameter, there was no significant two-way interaction (p=0.78) and no 
significant main effect for treatment (p=0.530; Figure 3). There was a significant main effect for 
time (p=0.041) with 30minPostEx higher than baseline. When 95% CI were employed, the PE 
treatment was significantly greater at 30minPostEx. For brachial artery blood flow, there was no 
significant two-way interaction (p=0.13), and no main effect for treatment (p=0.06). There was a 
main effect for time (p=0.001), demonstrating greater baseline flow, compared to 30minPI; 
30minPostEx greater than 30minPI; and IPost greater than baseline, 30minPI, and 30minPostEx. 
Blood flow was significantly greater IPost when PE was consumed (MD= 18.49 mL·min-1, 
p=0.05).  The 95% CI also demonstrated a significant difference for blood flow IPost when PE 
was consumed.  
There were no significant two-way interactions, main effects for treatment, or main 
effects for time for diastolic BP and SPO2. There was no significant two-way interaction or main 
effect for treatment for HR (p=0.81) and systolic BP (p=0.32). There was a significant main 
effect for time for HR (p<0.0001) with baseline significantly higher than 30minPI; IPost 
significantly higher than baseline, 30minPI, and 30minPostEx; 30minPostEx significantly higher 
than baseline and 30minPI. There was a significant main effect for time for systolic BP 
(p=0.001), with baseline significantly higher than 30minPostEx; 30minPI significantly higher 
than 30minPostEx; and IPost significantly higher than baseline, 30minPI, and 30minPostEx 
(Table 1). 
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Repetitions to Fatigue (RTF) 
 There was no significant difference for the number of repetitions completed for bench 
press (p=0.25) or leg press (p=0.15) when consuming PE or PL. However, bench press (MD= 
0.63 reps) and leg press (MD= 1.9 reps) repetitions were higher with the PE treatment. For vessel 
diameter, there was a significant interaction (p=0.008). Post hoc comparisons demonstrated a 
main effect for time (p=0.0001) and significant main effect for treatment (p=0.03). Vessel 
diameter IPostBench was significantly greater than baseline (MD= 0.026 cm; p=0.007) and 
30minPI (MD=0.022 cm, p=0.006); IPostLeg was significantly greater than 30minPI (MD= 
0.025 cm, p= 0.021). Vessel diameter was significantly greater with the PE treatment for 
IPostBench (MD= 0.029 cm; p=0.025), IPostLeg (MD= 0.042 cm; p=0.001), and 30minPostEx 
(MD= 0.027 cm; p=0.029; Figures 4 & 5). The 95% CI also demonstrated a significant 
difference for vessel diameter IPostBench, IPostLeg, and 30minPostEx.  
There was no significant interaction (p= 0.25) or main effect for treatment (p=0.117) for 
brachial artery blood flow. There was a significant main time effect for blood flow (p<0.001) 
with 30minPI lower than baseline (MD= -10.43 mL·min-1, p=0.013); IPostBench higher than 
baseline (MD=134.6 mL·min-1, p<0.0001), 30minPI (MD=144.6 mL·min-1, p<0.0001), IpostLeg 
(MD= 86.4 mL·min-1, p<0.0001), and 30minPostEx (MD= 135.2 mL·min-1, p<0.0001); IpostLeg 
was higher than baseline (MD= 48.2 mL·min-1, p<0.0001), 30min post ingestion (MD= 58.2 
mL·min-1, p<0.0001), 30min post exercise (48.8 mL·min-1, p<0.0001). When evaluating 95% CI, 
there was a significant difference in IPostLeg and 30minPostEx blood flow when PE was 
consumed. 
There was no significant interaction or main effect for treatment for HR, systolic BP, 
diastolic BP. There was a significant main time effect for HR (p< 0.0001), systolic BP (p=0.001), 
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and diastolic BP (p=0.009). Heart rate IPostLeg was significantly higher than baseline, 30minPI, 
IPostBench, and 30minPostEx; IPostBench was significantly higher than baseline, 30minPI, and 
30minPostEx; 30minPostEx was significantly higher than 30minPI. Systolic BP IPostLeg was 
significantly higher than baseline, 30minPI, and 30minPostEx; IPostBench was significantly 
higher than baseline, 30minPI, and 30minPostEx. Diastolic BP IPostBench was significantly 
lower than 30minPI (Table 1). SPO2 resulted in no significant interaction, main effect for time or 
treatment. 
 
DISCUSSION 
Previous studies on nitrate supplementation have resulted in enhanced exercise tolerance, 
oxygenation, and decreased blood lactate, and muscular soreness.2,4,6 Previous research has also 
demonstrated supplementation with dietary nitrate and polyphenols, such as PE, to have an 
ergogenic effect.4,9 The natural components of PE, including nitrate and polyphenols, may have 
additional benefits for endothelial function. Polyphenols specific to PE have demonstrated 
significant positive effects on endothelial-dependent vasodilation, more so than other fruits 
containing polyphenols.12,13 Previous research has demonstrated a potential important role of 
dietary nitrate in vascular and metabolic control, when converted to nitric oxide (NO), under 
periods of low oxygen availability/exercising state.50 The current study demonstrated beneficial 
effects of PE on blood flow and vessel diameter immediately following the RTF test and 30 
minutes post exercise of RSA and RTF. There was an improvement in peak power and average 
power output halfway through the RSA test from PE supplementation, which may suggest an 
ergogenic effect as a result of increased vessel diameter and blood flow.  
The culmination of previous research on nitrate supplementation and exercise 
performance has primarily examined beetroot, while few studies have examined pomegranate 
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juice or PE. Beetroot has also been shown to increase the amount of NO through the same NOS-
independent pathway, and has also been shown to improve performance.16,53 While there is 
potential thought that beetroot may improve skeletal muscle and mitochondrial efficiency 
through the same mechanism,50 additional ergogenic benefit from PE may result from the high 
polyphenol content.12,13 Trombold et al.3 demonstrated that chronic consumption of pomegranate 
juice attenuated muscular weakness, reduced soreness, and improved recovery, potentially as 
result of the high antioxidant content. In a study examining the effects of PE on high intensity 
running, PE increased time to exhaustion and delayed fatigue at 90% and 100% of peak velocity 
determined from a maximal oxygen uptake test.4 Results from Bailey et al.,2 when using beetroot, 
also demonstrated an increase in time to exhaustion and reduced oxygen cost at a fixed 
submaximal work rate. The current study evaluated more anaerobic tests, demonstrating an 
improvement in peak power output halfway through the RSA test as a result of one dose of PE 
supplementation. Similarly, when using beetroot juice for seven days, Kelly et al. 42 
demonstrated improved exercise tolerance at 60%, 70%, and 80% of peak power. In this same 
study, maximal peak power (100%) was not improved. Christensen et al.40 also demonstrated no 
significant effects at a maximal effort for oxygen kinetics, peak power output, time-trial 
performance, or RSA following the use of beetroot juice. Collectively, acute (~6 days) beetroot 
juice intake has failed to elicit improvements in maximal oxygen uptake.2,42,53,54 In contrast, 
acute supplementation of PE (one dose) and more chronic supplementation of beetroot (three 
weeks) may be advantageous for submaximal aerobic exercise. The current study is the first to 
demonstrate a potential benefit of PE on anaerobic peak power.  
 Previous research has shown nitrate supplementation may increase blood flow and vessel 
diameter.4,52 After ingestion, a portion of nitrate is taken up by salivary glands, reduced to nitrite, 
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and swallowed, while a substantial amount of nitrite enters the systemic circulation.55 Nitrate is 
then reduced to NO in blood and other tissues, which then can function in skeletal muscle to 
regulate blood flow, contractility, and mitochondrial respiration and biogenesis.56 In a similar 
study done previously in our lab, Trexler et al.4 demonstrated an increase in vessel diameter 30 
minutes after exercise (Δ=0.021 ± 0.04 cm) and an increase in blood flow 30 minutes post-
ingestion (Δ=11.0 ± 20.8 mL!min-1) of PE compared to a placebo. The current study results were 
similar for vessel diameter diameter 30 minutes after exercise (Δ=0.027 ± 0.04 cm) blood flow 
30 minutes post-ingestion (Δ=4.03 ± 18.9 mL!min-1), and support this previous research with 
enhanced blood flow immediately post leg press in the RTF and immediately post RSA. 
Additionally, in the current study, vasodilation was enhanced 30minPostEx in the RSA, 
immediately post bench press and leg press, and 30minPostEx in the RTF, as a result of PE 
supplementation.  
As a result of high concentration of nitrate and polyphenols, pomegranate may further 
increase the delivery of blood, oxygen, and energy substrates to skeletal muscle. Specific to 
pomegranate, the primary active polyphenols have been reported to be: flavonols, ellagitannins, 
and anthocyanins.12,13 Previous research with polyphenols has resulted in increased FMD and 
reduced BP.9,21 In elite athletes, FMD increased 30, 60, 90, and 120 minutes after consuming a 
polyphenol-rich drink, with FMD peaking at 60 minutes and returning to baseline 3 hours after 
ingestion.23 In the same study, there were no significant differences between placebo and the 
polyphenol-rich drink in time to completion, average wattage, or perceived exertion after a time-
trial. Yet, the athletes had lower plasma lactate levels before and after the test, and heart rate was 
significantly lower 2 minutes and 5 minutes post exercise. In contrast, the current study 
demonstrated no difference between PE and PL for HR, BP, or SP02 prior, immediately post, or 
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thirty minutes post exercise. There was also no difference in heart rate during the RSA test 
between PE and PL. Pomegranate juice has resulted in lower BP and improved endothelial 
function in clinical populations when consumed chronically.20,25,46 The current study was 
completed in a young, healthy population and may explain the lack of change in HR or BP. 
Oxygen saturation was measured at the finger for ease of access with no significant differences 
observed; whereas measuring SP02 at the working skeletal muscle may be more advantageous to 
determine saturation. As a result of previous research and lack of findings in the present study, 
pomegranate and polyphenols may be beneficial for cardiovascular health with more chronic 
consumption and in clinical populations. Future research evaluating acute consumption of PE in 
slightly compromised individuals may be beneficial.  
 Despite the positive findings in the present study, limitations do exist. The results of this 
study are limited to acute consumption, 30 minutes prior to exercise. Future research on PE may 
focus on optimal timing and dosage for enhancing blood flow, vessel diameter, and performance. 
Additional research on the effects of PE with varying modes and duration of exercise may help 
better determine the ergogenic utility of PE. Moreover, the participants in this study were 
recreationally active, resistance trained individuals with no adverse health conditions. Added 
research on untrained individuals, elite athletes, or individuals with health conditions or diseases 
would help to determine the generalizability effects of PE supplementation. 
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CHAPTER V 
CONCLUSION 
In conclusion, acute supplementation of PE resulted in enhanced vessel diameter, blood 
flow, and peak and average power output. These improvements are likely due to the high content 
of nitrate and polyphenols in PE, which have likely resulted in increased NO to enhance 
endothelial function and enhance exercise performance. While the majority of previous research 
on beetroot had participants ingest supplements chronically, the present study demonstrated PE 
to be effective when ingested 30 minutes before exercise. This timing, as well the ease of PE 
being in capsule form, may be advantageous to the athletic population. However, more research 
is needed to evaluate the effects PE when ingested chronically and in clinical populations. 
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TABLES 
 
Table 1. Average heart rate and blood pressure for pomegranate extract (PE) and placebo (PL) 
during repeated sprint ability (RSA) test and repetitions to fatigue (RTF) test (Mean ± SD). 
 
       Heart Rate            Blood Pressure 
 
                                PE      PL      PE   PL   
RSA   
Baseline  71.8 ± 10.4    73.1 ± 12.4      116/73 ± 11.5 116/76 ± 12.6 
30minPI  69.3 ± 12.6*    68.4 ± 9.0*      117/75 ± 11.4 119/74 ± 7.8 
IPost             152.2 ± 14.1*  151.5 ± 17.8*      138/73 ± 16.8* 134/74 ± 20.5* 
30minPostEx   90.0 ± 11.6*    91.6 ± 14.7*      110/72 ± 9.1* 108/71 ± 7.6* 
RTF 
Baseline  70.9 ± 13.4    68.8 ± 11.0      118/74 ± 10.7 117/73 ± 11.7 
30minPI  66.8 ± 13.2    64.9 ± 8.9      117/70 ± 12.2 116/74 ± 11.1 
IPostBench            134.5 ± 21.9* 138.6 ± 18.4*      125/67 ± 12.4* 125/67 ± 12.3* 
IPostLeg            149.5 ± 17.0* 150.7 ± 16.3*      131/71 ± 13.6* 135/71 ± 16.7* 
30minPostEx  73.7 ± 11.4    74.2 ± 9.3      109/71 ± 17.6 114/68 ± 10.8 
* denotes significant main effect for time (p<0.05). 
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FIGURES 
 
 
 
 
 
 
Figure 1. Overview of the study experimental design. Pomegranate Extract (PE); Placebo (PL); 
Blood pressure (BP); Oxygen saturation (SPO2); Flow mediated vasodilation (FMD); Repeated 
sprint ability (RSA); Repetitions to fatigue (RTF); 30 minutes post ingestion (30min PI); 
immediately post exercise (IPost); 30 minutes post exercise (30min PostEx). 
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Figure 2. Mean change scores ± 95% confidence intervals for peak power. * Indicates a 
significant difference when 0 is not included in the 95% confidence interval. 
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Figure 3. Changes in vessel diameter for pomegranate extract (PE) and placebo (PL) for repeated 
sprint ability test. Values were covaried for baseline measure differences. 
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Figure 4. Vessel diameter for pomegranate extract (PE) and placebo (PL) for bench press during 
the repetitions to fatigue test. * indicates significantly different from PL (p<0.05). 
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Figure 5. Vessel diameter for pomegranate extract (PE) and placebo (PL) for leg press during the 
repetitions to fatigue test. * indicates significantly different from PL (p<0.05). 
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